Benjamin L. Schlechter, MD

Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute

Articles by Benjamin L. Schlechter, MD

Benjamin L. Schlechter, MDColorectal Cancer | March 13, 2025
Dr. Schlechter also highlights how this research may effect long-term efficacy and durability of response in patients.
View More
Benjamin L. Schlechter, MDColorectal Cancer | March 13, 2025
Dr. Schlechter discusses a phase 1 dose escalation study of a novel coupled CAR-T therapy for patients with mCRC.